TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15295325

Group type: EXPERIMENTAL
Intervention: Quartz fiber dowel with 1.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber dowel with 1.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber plus zirconia dowel with 1.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Zirconia dowel with 1.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Quartz fiber dowel with 1.5 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber dowel with 1.5 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber plus zirconia dowel with 1.5 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Zirconia dowel with 1.5 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Quartz fiber dowel with 2.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber dowel with 2.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Glass fiber plus zirconia dowel with 2.0 mm ferrule
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Zirconia dowel with 2.0 mm ferrule
Number of subjects: 123
Study: 10686384

Group type: EXPERIMENTAL
Intervention: Infrequent higher-pitch 'deviant' tones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequent 'standard' tones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attended tones (both deviant and standard)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ignored tones (both deviant and standard)
Number of subjects: 0
Study: 9087467

Group type: EXPERIMENTAL
Intervention: Normothermic group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Hypothermic group
Number of subjects: 300
Study: 8470415

Group type: EXPERIMENTAL
Intervention: Nifedipine (NIF) 2 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isradipine (ISR) 0.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nisoldipine (NIS) 0.5 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Felodipine (FEL) 0.6 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 20
Study: 3715709

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (total dose 66 Gy, single dose 1.8 to 2 Gy, 1 to 2 fractions daily, total treatment period 4 to 5.5 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation with treatment period of less than four weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Accelerated fractionation with treatment period of more than five weeks
Number of subjects: 0
Study: 28975719

Group type: EXPERIMENTAL
Intervention: Partially absorbable lightweight mesh (ULTRAPRO™)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Multifilament polyester anatomical mesh (Parietex™)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both meshes
Number of subjects: 85
Study: 27049879

Group type: EXPERIMENTAL
Intervention: VR-based balance exercises
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional balance exercises
Number of subjects: 18
Study: 24654636

Group type: EXPERIMENTAL
Intervention: Breastfeeding counseling sessions held at the maternity ward and at home (at 7, 15, 30, 60, and 120 days postpartum)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Breastfeeding counseling sessions
Number of subjects: 323
Study: 22979900

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic cholecystectomy (SILC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (LC)
Number of subjects: 100
Study: 20668414

Group type: EXPERIMENTAL
Intervention: Ligasure hemorrhoidectomy (LH)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Stapled hemorrhoidopexy (SH)
Number of subjects: 68
Study: 18606504

Group type: EXPERIMENTAL
Intervention: Oxycodone (10, 20 and 40 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydrocodone (15, 30 and 45 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hydromorphone (10, 17.5 and 25 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 17225548

Group type: EXPERIMENTAL
Intervention: Qianggan capsule, 5 granules twice per day for 3 months
Number of subjects: 122

Group type: COMPARATOR
Intervention: Tiopronin, 0.2 gram three times per day for 3 months
Number of subjects: 122
Study: 12207143

Group type: EXPERIMENTAL
Intervention: Fentanyl during anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: No fentanyl
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 9695642

Group type: COMPARATOR
Intervention: Serum erythropoietin concentration in women with benign tumors
Number of subjects: 70

Group type: COMPARATOR
Intervention: Serum erythropoietin concentration in women with malignant tumors
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Uterine or ovarian malignancy
Number of subjects: 70
Study: 8581337

Group type: EXPERIMENTAL
Intervention: Acetazolamide, 6 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no acetazolamide)
Number of subjects: 12
Study: 2702851

Group type: EXPERIMENTAL
Intervention: bezafibrate (600 mg/day)
Number of subjects: 59

Group type: COMPARATOR
Intervention: gemfibrozil (1200 mg/day)
Number of subjects: 59
Study: 138608

Group type: EXPERIMENTAL
Intervention: 0.1% retinoic acid derivative Ro 11-1430
Number of subjects: 31

Group type: COMPARATOR
Intervention: 0.05% retinoic acid (control)
Number of subjects: 31
Study: 31882017

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 30216113

Group type: EXPERIMENTAL
Intervention: Patients with heart failure and LV dyssynchrony
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Systolic force ratio in patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Diastolic force ratio in patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 31
Study: 27450625

Group type: EXPERIMENTAL
Intervention: SCORE2 recruitment techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard-of-care treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly e-newsletter and communication by SCORE2 Executive Committee
Number of subjects: 0
Study: 24184996

Group type: EXPERIMENTAL
Intervention: HHS (4 mL/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HES (7 mL/kg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: RL (7 mL/kg)
Number of subjects: 36
Study: 22436836

Group type: EXPERIMENTAL
Intervention: Exercisers (defined as women who met specific criteria for frequency: three times per week, duration: 20 minutes/session, intensity: moderate, mode: aerobic)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Exercisers
Number of subjects: 119

Group type: COMPARATOR
Intervention: Nonexercisers
Number of subjects: 119

Group type: COMPARATOR
Intervention: Exercisers and Nonexercisers
Number of subjects: 119
Study: 19397392

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 333
Study: 17548446

Group type: EXPERIMENTAL
Intervention: Efficacy-enhancement exercise condition
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 26
Study: 15304040

Group type: EXPERIMENTAL
Intervention: all-trans retinoic acid (ATRA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: chemotherapy
Number of subjects: 25
Study: 12101335

Group type: EXPERIMENTAL
Intervention: Laparoscopic shortening and plication of uterosacral ligaments with modified Gilliam suspension
Number of subjects: 31
Study: 10431796

Group type: EXPERIMENTAL
Intervention: Group A (intact posterior capsule, posterior chamber monofocal IOL)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Group B (ruptured or removed posterior capsule, anterior chamber monofocal IOL)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (healthy control eyes)
Number of subjects: 126
Study: 7653813

Group type: EXPERIMENTAL
Intervention: Epinephrine 0.12 mg, morphine 0.2 mg, and hyperbaric tetracaine 12 mg intrathecally (EMT group, n = 11)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Morphine 0.2 mg and hyperbaric tetracaine 12 mg intrathecally (MT group, n = 13)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Epinephrine 0.12 mg and hyperbaric tetracaine 12 mg intrathecally (ET group, n = 12)
Number of subjects: 36
Study: 2696658

Group type: EXPERIMENTAL
Intervention: Jejunal infusion of nutrients at 1.3 kcal/min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Jejunal infusion of nutrients at 3.3 kcal/min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (intragastric instillation of a 490 kcal, 400 ml, homogenized meal)
Number of subjects: 6
Study: 414267

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 75 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 95 dBA white noise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 25 mg + 95 dBA white noise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chlorpromazine 75 mg + 95 dBA white noise
Number of subjects: 12
Study: 31083198

Group type: EXPERIMENTAL
Intervention: Cocktail analgesic injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 36
Study: 28511086

Group type: EXPERIMENTAL
Intervention: Pipelle biopsy (twice in the luteal phase prior to IVF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control (no intervention prior to IVF)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Pipelle biopsy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control
Number of subjects: 111
Study: 25790229

Group type: EXPERIMENTAL
Intervention: Hepatic arterial infusion (HAI) with 5-fluorouracil plus systemic antineoplastons (A10-I infusion followed by per-oral AS2-1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Hepatic arterial infusion (HAI) with 5-fluorouracil alone (control arm)
Number of subjects: 65
Study: 23987192

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol
Number of subjects: 10
Study: 22052027

Group type: EXPERIMENTAL
Intervention: Calf compression sleeves
Number of subjects: 14
Study: 19884575

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) exercise group (n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 38
Study: 17576710

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Previous cataract surgery
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Barriers to cataract surgery
Number of subjects: 1000
Study: 15107387

Group type: EXPERIMENTAL
Intervention: Bystander CPR (ByCPR) performed within two minutes
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Bystander CPR (ByCPR) performed after two minutes
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Witnessed cardiac arrest
Number of subjects: 874
Study: 11266479

Group type: EXPERIMENTAL
Intervention: Peg-in-hole construct
Number of subjects: 30

Group type: COMPARATOR
Intervention: End-to-end construct
Number of subjects: 30

Group type: COMPARATOR
Intervention: V construct
Number of subjects: 30
Study: 9043026

Group type: EXPERIMENTAL
Intervention: RT plus continuous infusion of 1 g m(‐2) day(‐1) fluorouracil for 5 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: RT alone (20 Gy in five daily fractions)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: RT plus fluorouracil
Number of subjects: 200

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 200
Study: 2022274

Group type: EXPERIMENTAL
Intervention: Basal body temperature (BBT) scheduling
Number of subjects: 74

Group type: COMPARATOR
Intervention: Luteinizing hormone (LH) monitoring scheduling
Number of subjects: 74
Study: 6751456

Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy with excision of the ulcer (HSV + E)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Billroth I partial gastrectomy (BI)
Number of subjects: 56
Study: 29258584

Group type: EXPERIMENTAL
Intervention: 25 mg tapentadol twice daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 75 mg tapentadol twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAIDs or paracetamol
Number of subjects: 60
Study: 24682378

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage system (cell saver)
Number of subjects: 110

Group type: COMPARATOR
Intervention: No cell saver
Number of subjects: 110
Study: 24884670

Group type: EXPERIMENTAL
Intervention: Hypertension vignette case with a Belgian patient (non-minority)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Hypertension vignette case with a Moroccan patient (minority)
Number of subjects: 171
Study: 22800664

Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 20200419

Group type: EXPERIMENTAL
Intervention: Ethanol-wet-bonding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water-wet-bonding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water-overwet-bonding
Number of subjects: 0
Study: 18342591

Group type: EXPERIMENTAL
Intervention: Viewing of operative photographic pictures
Number of subjects: 318

Group type: COMPARATOR
Intervention: Not viewing operative photographic pictures
Number of subjects: 318
Study: 15978304

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg plus insulin (PIO + INS)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Placebo plus insulin (PLB + INS)
Number of subjects: 289
Study: 12925332

Group type: EXPERIMENTAL
Intervention: Symptom Checklist
Number of subjects: 0
Study: 10486687

Group type: EXPERIMENTAL
Intervention: Intraoperative use of narcotic analgesics
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Vitrectomy
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Scleral buckling
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Combined vitrectomy‐scleral buckling
Number of subjects: 257
Study: 10369648

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (10 ppm)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sodium nitroprusside
Number of subjects: 10

Group type: COMPARATOR
Intervention: Prostacyclin PGI2
Number of subjects: 10
Study: 1532551

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (150 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (150 micrograms)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intrathecal sufentanil (IS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Epidural sufentanil (ES)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups (IS and ES)
Number of subjects: 24
Study: 2984332

Group type: EXPERIMENTAL
Intervention: Methylprednisolone, 1 g intravenously daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACTH regime
Number of subjects: 0
Study: 29627431

Group type: EXPERIMENTAL
Intervention: Pecs I (bupivacain 0.25%, 10mL) and Pecs II (bupivacain 0.25%, 20mL) block
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pecs I and II blocks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no block treatment)
Number of subjects: 54
Study: 29130615

Group type: EXPERIMENTAL
Intervention: In-office bleaching using 40% hydrogen peroxide gel for one hour
Number of subjects: 40
Study: 27018530

Group type: EXPERIMENTAL
Intervention: Therapeutic Evaluative Conditioning (TEC) app
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control app
Number of subjects: 408
Study: 24612524

Group type: EXPERIMENTAL
Intervention: Stainless steel volar plate (Trimed™ Volar Plate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Titanium volar plate (Medartis® Aptus Volar Plate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 22819432

Group type: EXPERIMENTAL
Intervention: AMR101 4 g/day
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: AMR101 2 g/day
Number of subjects: 702

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 702
Study: 20435363

Group type: EXPERIMENTAL
Intervention: Variant alleles at ‐509 and codons 10 and 25 of the TGFβ1 locus
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Unmatched analysis of 82 cases
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Unmatched analysis of 108 controls
Number of subjects: 1716
Study: 18043103

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LPS), n = 113
Number of subjects: 226

Group type: COMPARATOR
Intervention: Open surgery, n = 113
Number of subjects: 226
Study: 16519092

Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 12399287

Group type: EXPERIMENTAL
Intervention: 75 g extruded oat bran (11 g beta-glucan)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 75 g wheat bran (1 g beta-glucan)
Number of subjects: 8
Study: 10550154

Group type: EXPERIMENTAL
Intervention: FU+LV (leucovorin-modulated fluorouracil)
Number of subjects: 2151

Group type: COMPARATOR
Intervention: FU+LEV (fluorouracil and levamisole)
Number of subjects: 2151

Group type: COMPARATOR
Intervention: FU+LV+LEV (fluorouracil, leucovorin, and levamisole)
Number of subjects: 2151
Study: 7576933

Group type: EXPERIMENTAL
Intervention: IL-3 (0.5, 1.0, 2.5, or 5.0 micrograms/kg/day)
Number of subjects: 0
Study: 2072403

Group type: EXPERIMENTAL
Intervention: Individual therapy format
Number of subjects: 80

Group type: COMPARATOR
Intervention: Group therapy format
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Inclusion of patient's partner in therapy
Number of subjects: 80
Study: 7347354

Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal 'skinny' endoscopy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Radiology
Number of subjects: 125
Study: 30474700

Group type: EXPERIMENTAL
Intervention: SMOF-lipid
Number of subjects: 160

Group type: COMPARATOR
Intervention: MCT/LCT
Number of subjects: 160
Study: 28623918

Group type: EXPERIMENTAL
Intervention: gyejibokryung-hwan (GBH) or dangguijagyag-san (DJS)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo granules
Number of subjects: 116
Study: 26471036

Group type: COMPARATOR
Intervention: Annual immunologic fecal occult blood testing (I-FOBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biennial immunologic fecal occult blood testing (I-FOBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 0
Study: 23497529

Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional hand exercises
Number of subjects: 30
Study: 21355639

Group type: EXPERIMENTAL
Intervention: EX/RP therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EX/RP therapy augmented by motivational interviewing strategies
Number of subjects: 30
Study: 18799777

Group type: EXPERIMENTAL
Intervention: Healthy Living Program (3 intervention modules of 5 sessions each)
Number of subjects: 270
Study: 17292647

Group type: EXPERIMENTAL
Intervention: 30 mg codeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 mg codeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15494804

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 34
Study: 11561074

Group type: EXPERIMENTAL
Intervention: Enadoline (80 microg/70 kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Butorphanol (1.5, 3, and 6 mg/70 kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Enadoline and Butorphanol
Number of subjects: 8
Study: 9609980

Group type: EXPERIMENTAL
Intervention: Baghdadin device (direct current electrotherapy)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Sodium stibogluconate
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (untreated lesions)
Number of subjects: 54
Study: 7821310

Group type: EXPERIMENTAL
Intervention: L-acetylcarnitine (30 mg x kg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: L-propionylcarnitine (30 mg x kg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (1.25 mg i.v. bolus)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (matched subjects)
Number of subjects: 22
Study: 3276389

Group type: EXPERIMENTAL
Intervention: Supportive care with combination chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supportive care
Number of subjects: 0
Study: 29659478

Group type: EXPERIMENTAL
Intervention: Taekwondo training (TKD), 16 weeks, once a week for 60 min
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Taekwondo training (TKD)
Number of subjects: 30
Study: 29098259

Group type: EXPERIMENTAL
Intervention: CAD/CAM zirconia all‐ceramic crown
Number of subjects: 46

Group type: COMPARATOR
Intervention: Cobalt‐chromium alloy porcelain‐fused‐to‐metal crown
Number of subjects: 46

Group type: COMPARATOR
Intervention: Silver‐palladium alloy porcelain‐fused‐to‐metal crown
Number of subjects: 46
Study: 26161468

Group type: EXPERIMENTAL
Intervention: Daily communication and language therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weekly therapy sessions
Number of subjects: 0
Study: 22951075

Group type: EXPERIMENTAL
Intervention: Intragastric dual balloon
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diet and exercise alone (Control Group)
Number of subjects: 30
Study: 19953227

Group type: EXPERIMENTAL
Intervention: 40 mg cortisol
Number of subjects: 30
Study: 18155965

Group type: EXPERIMENTAL
Intervention: Postoperative cognitive rehabilitation
Number of subjects: 112

Group type: COMPARATOR
Intervention: No postoperative cognitive rehabilitation (Control)
Number of subjects: 112
Study: 15706008

Group type: EXPERIMENTAL
Intervention: Cholesterol-rich diet (800 mg/d cholesterol)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal diet (250 mg/d cholesterol)
Number of subjects: 21